Progenics Pharmaceuticals Inc. (PGNX) jumped 8.3% or 0.36 to $4.7. It is near 1.80 million shares traded, which is 139.21% compare to the average total volume 1.29 million. The market cap of PGNX is $397.35 million. The year to date change is -21.14%. The 52 week price range is from $4.24 to $9.42. Price of PGNX have changed -13.55% during last week. It have changed -17.18% over last month, -41.51% over last 3 months, -50.63% over last 6 months and -23.05% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PGNX is 5.38. It is 14.47% above current price. The 200-day Moving Averages for PGNX is 7.08. It is 50.64% above current price. The 52-week High is 9.42. It is 100.43% from the current price. The 52-week Low is 4.24. It is -9.79% from current price.
There are some statistics of PGNX. It is has market cap $397.35 million. The share outstanding is 84.54 million. The average volume is 1.29 million. The percent of top 15 Institution holding is 139.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PGNX is -63.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PGNX is -33.18%.